Cost-effectiveness of sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer in China

• Shuo Kang,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Medical Insurance Office, The Second Hospital of Hebei Medical University, Shijiazhuang, PR China

  ⨯
• Shuo Yang,

  Roles Writing – review & editing

  Affiliation School of Pharmacy, Hebei Medical University, Shijiazhuang, PR China

  ⨯
• Yize Jia,

  Roles Writing – review & editing

  Affiliation School of Pharmacy, Hebei Medical University, Shijiazhuang, PR China

  ⨯
• Shan Zhao

  Roles Writing – original draft, Writing – review & editing

  * E-mail: zhaoshan66@126.com

  Affiliation Department of Oncology, The Second Hospital of Hebei Medical University, Shijiazhuang, PR China

  https://orcid.org/0009-0008-5170-6771

  ⨯